May 22, 2018
CHICAGO: The first findings from a collaborative study within the American College of Surgeons (ACS) Cancer Programs—and published today in the Journal of the American Medical Association (JAMA)—showed no significant association between frequency of surveillance testing and the time to detection of recurrence for colorectal cancer patients.
The study is an effort of the ACS Clinical Research Program and the Commission on Cancer, and uses data from the National Cancer Database, which is jointly sponsored by the ACS and the American Cancer Society. It focuses on post-treatment surveillance for breast, colon, and lung cancers, and was funded by the Patient Centered Outcomes Research Institute.
This portion of the study included more than 8,500 patients and was the first of eight manuscripts accepted for publication from the larger study conducted in 2015. The corresponding author is George J. Chang, MD, FACS, of the University of Texas MD Anderson Cancer Center, Houston.
To learn more about the study results, and to view the full text article, visit the JAMA website.
"FACS" designates that a surgeon is a Fellow of the American College of Surgeons.
The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and improve the quality of care for all surgical patients. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has approximately 90,000 members and is the largest organization of surgeons in the world. "FACS" designates that a surgeon is a Fellow of the American College of Surgeons.